Patents by Inventor Wenqing Ye

Wenqing Ye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11821273
    Abstract: The invention discloses an experimental system and a method for wellbore pressure testing under the coexistence of gas-kick and loss-circulation, comprising a drill string simulator, a wellbore simulator and a complex stratigraphic structure simulator communicated in sequence from top to bottom; further comprising a medium return pipeline for collecting the returning test liquid and a medium leakage module for collecting the leaking test liquid; further comprising a data acquisition system for collecting data during testing. In the present invention, the experimental system has a simple structure, and the experimental method can comprehensively cover the three stages of circulating, well shut-in and well killing during the occurrence of coexistence of gas-kick and loss-circulation, multiple groups of experiments can be conducted by changing a single variable at the same stage, thus making the experimental test results applicable to all stages of wellbore pressure control in drilling operation.
    Type: Grant
    Filed: August 26, 2022
    Date of Patent: November 21, 2023
    Assignee: Southwest Petroleum University
    Inventors: Jie Zhang, Xin Li, Zhilin Li, Qiang Wei, Xianjie He, Wenqing Ye
  • Publication number: 20080183003
    Abstract: The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and compositions.
    Type: Application
    Filed: February 4, 2008
    Publication date: July 31, 2008
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Yuqiang Wang, Wenqing Ye, James W. Larrick, Jonathan S. Stamler, Stuart A. Lipton
  • Patent number: 7326730
    Abstract: The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and compositions There are a variety of neurological disorders that can be treated using the present invention, including, for example, the following: neurological disorders arising from trauma, ischemic or hypoxic conditions that can be treated include stroke, hypoglycemia, cerebral ischemia, cardiac arrest, spinal cord trauma, head trauma, perinatal hypoxia, cardiac arrest and hypoglycemic neuronal damage; neurodegenerative disorders such as epilepsy, Alzheimer's disease, Huntington's disease Parkinsonism, and amyotrophic lateral sclerosis; other diseases or disorders such as convulsion, pain, depression, anxiety, schizophrenia, muscle spasms, migraine headaches, urinary incontinence, nicotine withdrawal, opiate tolerance and withdrawal, emesis, brain edema
    Type: Grant
    Filed: November 17, 2005
    Date of Patent: February 5, 2008
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Yuqiang Wang, Wenqing Ye, James W. Larrick, Jonathan S. Stemler, Stuart A. Lipton
  • Publication number: 20060106222
    Abstract: The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and compositions There are a variety of neurological disorders that can be treated using the present invention, including, for example, the following: neurological disorders arising from trauma, ischemic or hypoxic conditions that can be treated include stroke, hypoglycemia, cerebral ischemia, cardiac arrest, spinal cord trauma, head trauma, perinatal hypoxia, cardiac arrest and hypoglycemic neuronal damage; neurodegenerative disorders such as epilepsy, Alzheimer's disease, Huntington's disease Parkinsonism, and amyotrophic lateral sclerosis; other diseases or disorders such as convulsion, pain, depression, anxiety, schizophrenia, muscle spasms, migraine headaches, urinary incontinence, nicotine withdrawal, opiate tolerance and withdrawal, emesis, brain edema
    Type: Application
    Filed: November 17, 2005
    Publication date: May 18, 2006
    Inventors: Yuqiang Wang, Wenqing Ye, James Larrick, Jonathan Stamler, Stuart Lipton
  • Publication number: 20040029929
    Abstract: The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and compositions.
    Type: Application
    Filed: August 4, 2003
    Publication date: February 12, 2004
    Inventors: Yuqiang Wang, Wenqing Ye, James W. Larrick, Jonathan S. Stamler, Stuart A. Lipton
  • Patent number: 6620845
    Abstract: The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and compositions.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: September 16, 2003
    Assignee: NeuroMolecular, Inc.
    Inventors: Yuqiang Wang, Wenqing Ye, James W. Larrick, Jonathan S. Stemler, Stuart A. Lipton
  • Publication number: 20030008889
    Abstract: The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and compositions.
    Type: Application
    Filed: July 19, 2002
    Publication date: January 9, 2003
    Inventors: Yuqiang Wang, Wenqing Ye, James W. Larrick, Jonathan S. Stamler, Stuart A. Lipton
  • Patent number: 6444702
    Abstract: The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and compositions.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: September 3, 2002
    Assignee: NeuroMolecular, Inc.
    Inventors: Yuqiang Wang, Wenqing Ye, James W. Larrick, Jonathan S. Stemler, Stuart A. Lipton